Shows
Pharma Market Access Insights - from Petauri EvidenceNavigating US payer evidence needs to optimise market accessSend us a textWhat clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How should evidence be generated, synthesised, and presented for the US market?In this episode, Clare Foy (Director – Global Market Access, Mtech Access) interviews colleagues Nicole Lodowski (Managing Director, Petauri Evidence) and Bob Nordyke (Senior Advisor, Petauri Evidence) about US payer evidence challenges.We explore the evolving evidence needs for US payers. Nicole and Bob share unique perspectives around their ex...
2024-11-2757 min
Pharma Market Access Insights - from Petauri EvidenceBest practice RWE approaches to support economic modelling for HTASend us a textHow can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to solve common challenges with treatment comparison?Here, Mtech Access are joined by experts from Arcturis and Delta Hat. Dan Howard (Associate Director – Health Economics, Mtech Access) shares some of the challenges that our clients face when developing HTA-ready health economic models with limited clinical trial data. Joseph O’Reilly (Principal Medical Statistician, Arcturis) introduces solutions to these challenges using RWD and RWE approaches. Nick Latimer (Analyst, Delta Hat; Prof...
2024-11-2059 min
Pharma Market Access Insights - from Petauri EvidenceNHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to ChristmasSend us a textHow is the NHS preparing for winter? Which challenges are the most pressing for NHS decision-makers? How can industry best engage and support NHS decision-makers in the next few months?In August, Karen Cooper (Senior Consultant – NHS Insight & Interaction, Mtech Access) was joined by Jo Turl (Former Director of Commissioning, Devon ICS) to explore these challenges.Jo and Karen discuss:How ICBs and Directors of Commissioning prepare for winter pressuresThe current key areas of focus at Place and ICB levelSpecific challenges and pressures facing the NHS now and in...
2024-11-181h 02
Pharma Market Access Insights - from Petauri EvidenceNHS primary care panel – the GP Contract and Operational Planning GuidanceSend us a textWhat can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future of primary care? What are the biggest challenges facing primary care in 2024–25?In this webinar, Karen Cooper (Senior Consultant – NHS Insight & Interaction, Mtech Access) spoke to a panel of NHS Associates about the current state and future of primary care and what this means for industry. Our panellists were:- Jack Wagstaff (Place Leader, Surrey Heartlands Health and Care Partnership, Chie...
2024-09-101h 02
Pharma Market Access Insights - from Petauri EvidenceMarket access and reimbursement in Canada – changes at CADTHSend us a textWhat do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? In this webinar, Clare Foy (Director – Global Market Access, Mtech Access) interviewed Don Husereau (Adjunct Professor of Medicine, The University of Ottawa).We take a look at the market access, health policy, and health technology assessment in Canada. Clare Foy and Don Husereau explore:The market access landscape in CanadaUpcoming changes at CADTHWhat Canadian payers expect from your val...
2024-06-2047 min
Pharma Market Access Insights - from Petauri EvidenceRare Disease market access in the MENA and Nordic regionsSend us a textWhere will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the EU4 and the US, but have you thought about other markets? Have you looked at the reimbursement requirements for rare disease products in the Nordic markets? Have you explored opportunities in growth markets, such as those in the Middle East and North Africa (MENA) region?In this webinar, our Global Market Access team compare and contrast access opportunities and challenges for r...
2024-05-1059 min
Pharma Market Access Insights - from Petauri EvidenceHow does funding flow in NHSE Regions?Send us a textWhich decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with Region leaders?We sit down with guest speaker Richard Smale (Interim Director of System Co-ordination, NHS England [NHSE] – South West) for an all-encompassing discussion that explored finance, funding flows, system priorities, and the decision-making process in NHS Regions.Richard heads up system co-ordination work across the NHS South West Region. The Region has seven Integrated Care Boards (ICBs), 22 Trusts, ni...
2024-04-091h 00
Pharma Market Access Insights - from Petauri EvidenceNHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)Send us a textWhat do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a general election and a potential Labour government on the horizon, how can NHS and industry drive forward improvements and innovation?Host Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) was joined by guest speakers Debbie Morgan (Director of Service Improvement and Transformation, Cambridge University Hospitals NHS Foundation Trust), Ellen Rule (Deputy CEO/Director of Strategy & Transformation, Gloucestershire Integrated Care Board) and Dr Viren Mehta (GP Pa...
2024-04-091h 02
Pharma Market Access Insights - from Petauri EvidenceEvidence strategy for Medical Technologies and DiagnosticsSend us a textHere, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies.Have you established the clinical and economic value of your medical device, diagnostic or digital technology? Do you have the evidence required to support your value proposition? Would a health technology assessment (HTA) route be appropriate for your product? What will payers, HTA agencies, and other key decision makers be looking for? And how should this information be presented?In this episode, our experts in HTA, health economics, and commercialisation explore:- How to...
2024-03-1253 min
Pharma Market Access Insights - from Petauri EvidenceHow to set your Pharma or Medtech product up for success in the US marketSend us a textHow can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice commercialisation strategy for healthcare products launching in the US market.Clare Foy (Director – Global Market Access, Mtech Access) speaks to Janice MacLennan (Pharma and Medtech brand strategist and founder of NMBLR) about how market access, HEOR and commercialisation leads in Pharma and Medtech can best support overarching product and brand strategy, with a focus on launch challenges in the US market.
2024-02-2643 min
Pharma Market Access Insights - from Petauri EvidenceWhat's happening with specialised commissioning in the NHS?Send us a textWhat’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty?Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in the NHS and what to expect as we head into 2024.Malcolm Qualie and David Thorne explored:Specialised commissioning in the NHSThe risks and opportunities that devolution to ICBs will bringWhat we ca...
2024-02-121h 00
Pharma Market Access Insights - from Petauri EvidenceIntegrated care in NHS Wales – what can England learn from its neighbour?Send us a textWhat does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England?Paul Mears (CEO, Cwm Taf Morgannwg University Health Board) joins Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) to explore the integrated care model in Wales and the lessons England can take from the Welsh experience.In this NHS Whispers webinar, guest speaker Paul Mears shares his experiences leading a Welsh health board. The 7 Health Boards in Wales have been operating as in...
2024-01-1756 min
Pharma Market Access Insights - from Petauri EvidenceMarket access in Italy: Reforms at AIFASend us a textClare Foy (Director – Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer) about the market access landscape in Italy, particularly regarding changes at the Agenzia Italiana del Farmaco (AIFA).We explore:- The nature of the Italian market and the reimbursement process- Pricing and market access considerations when launching in Italy- What the reforms at AIFA mean for market access and managed entry agreements- How the AIFA changes specifically im...
2023-12-1843 min
Pharma Market Access Insights - from Petauri EvidenceUnmet need in NHS primary care – How can industry best support PCN leaders?Send us a textDr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how industry can best support primary care leaders and GPs as we head into winter, 2024 and beyond.Former ‘GP of the year’ and strategic influencer over primary care policy, Dr Farzana Hussain, discusses the unmet needs in primary care, how primary care leaders are responding to these challenges, and where industry can best offer support.Phil and Farzana discuss: How u...
2023-11-281h 00
Pharma Market Access Insights - from Petauri EvidencePopulation health management: a community effort across health and life sciencesSend us a textHow can our community support NHS leaders to deliver a data-led, people-centric health service?Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) to explore the power of data, the role of community and how the health and life sciences ecosystem can support the NHS’s population health management goals.Population health management has the potential to be a powerful tool for healthcare systems, effecting the way health and care is strategised, budgeted, targeted, and delivered. We see a fu...
2023-11-011h 04
Pharma Market Access Insights - from Petauri Evidence6 areas of UK health policy for Medtech to pay attention toSend us a textHow is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators?Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) speaks to William Lee (Head of Policy and Compliance, British Healthcare Trades Association [BHTA]) about health policy, regulation and its implications for Medtech, Health technologies, and Medical Device market access.With the challenges of the pandemic and the changes brought in following Brexit, policy and compliance in the UK has been on shifting sands for several years now. With many predicting a...
2023-10-161h 01
Pharma Market Access Insights - from Petauri EvidenceMarket access in the German speaking marketsSend us a textHere we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets.Clare and Stefan discuss: - Preparing for access to Switzerland – a European market outside the EU - Pricing strategy and HTA decision-making in Austria under the new Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA) - Launching in Germany – is this still one of the mo...
2023-08-2957 min
Pharma Market Access Insights - from Petauri EvidenceThe role of nursing in driving digital change in the NHSSend us a textHow are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinical teams to support improved patient care? And how can Medtech, Digital and Biotech innovators collaborate with the front-line nursing teams in the NHS to drive transformation?Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) speaks to Jennie Smith, registered nurse, Medtech launch specialist and our new Director of NHS Insight & Interaction at Mtech Access.Phil and Jennie explore: - The transformative power of technology in t...
2023-07-2654 min
Pharma Market Access Insights - from Petauri EvidenceMarket access for digital therapies and digital medicinesSend us a textIn this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcomes.In the webinar, Clare asks Shefali about:The opportunities for digital technologies in neurology and how they may impact existing care pathways in the futureHow the digital technology market differs from the pharmaceutical marketRegulatory and reimbursement challenges for digital tech...
2023-07-1942 min
Pharma Market Access Insights - from Petauri EvidencePrimary Care and ICBs – what is the next step in the integration journey?Send us a textHow will changes to the structure of primary care impact decision making?How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows be impacted?Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Tim Goodson (Executive Officer, Dorset General Practice Alliance) to explore how primary care is evolving and what this means for decision making, funding, and relationships with industry.Phil and Tim explore:The integration journey across primary careEvolving relationships and structures in primary...
2023-05-151h 01
Pharma Market Access Insights - from Petauri EvidenceData-led transformation in the NHS - partnering to optimise patient careSend us a textIs data the key to transforming healthcare systems and patient care?What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner with the NHS to share data, transform services, and find smarter, faster way to improve patient care?Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Stephen Slough (Chief Digital Information Officer, NHS Dorset) to explore how, through the catalyst of partnership, new technologies and data have the potential to transform healthcare.
2023-03-311h 02
Pharma Market Access Insights - from Petauri EvidenceInnovating for better health – research, collaboration and innovation in the NHSSend us a textHow and where can innovation drive improvements in care and deliver better health for the population?How is the NHS looking to collaborate with key partners across industry and academia? What innovations are set to transform care? What role do Academic Health Science Networks (AHSNs) play and how can partners best engage with them?Prof Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Bill Gillespie (Chief Executive Officer, Wessex AHSN) to explore innovation in the NHS, the role of AHSNs and the potential for...
2023-03-0757 min
Pharma Market Access Insights - from Petauri EvidenceHealthcare, economics and society – unlocking NHS collaborationSend us a textWill NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change?What social and economic value do ICSs offer the wider population they serve? How will industry support ICSs to deliver population-based health and social benefits?Prof Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Michael Wood (Head of Health Economic Partnerships, NHS Confed) for a far-reaching discussion around system integration, population health management, and the NHS’s social and economic potential.In...
2023-01-3059 min
Pharma Market Access Insights - from Petauri EvidenceSpecialised Commissioning in the NHS – What do you need to know nowSend us a textThe proposed new NHSE systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects or policy have been published in ways that are hard to access and even harder to interpret. Here, we gather an expert panel to discuss what proposed new NHSE systems for specialised commissioning mean in practice.In this episode, we explore: - What’s new for Specialised Commissioning and what’s set to change? - What are the potential implications of the proposed change...
2023-01-131h 00
Pharma Market Access Insights - from Petauri EvidenceWhy are we waiting? - Pressures facing the NHS and how to deliver changeSend us a textWith so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can industry work with the NHS to improve patient flow to get people appropriate treatment sooner and limit the harm caused by waiting? Prof Phil Richardson (new Chief Innovation Officer, Mtech Access and until recently, Executive Director at NHS Dorset ICS) joins Tom Clarke (Director, Mtech Access) explored all this and more.In this NHS Whispers webinar, we explore: - Th...
2022-11-291h 00
Pharma Market Access Insights - from Petauri EvidencePriority setting in primary care - NHS insightsSend us a textHow is the NHS balancing competing challenges as we head through integration and towards winter? How are priorities set and what does system planning look like in primary care?Dr Alex Degan (Primary Care Medical Director, Devon Integrated Care System [ICS]) joins Tom Clarke (Director, Mtech Access) to explore all this and more.In this episode, we explore how primary care leaders are reacting to the ongoing changes and challenges facing the NHS. Tom Clarke interviews primary care leader Alex Degan to explore:How priorities are set and...
2022-10-1859 min
Pharma Market Access Insights - from Petauri EvidenceIntegrated Care Systems go live in the NHS - reflections after 3 weeksSend us a textOn 1st July we saw the introduction of legislation for Integrated Care Systems (ICSs) in the NHS. In the weeks since, what has changed for healthcare leaders, practitioners and patients? What are the key priorities for NHS decision-makers and what is getting in the way of change? How can Pharma and Medtech support their NHS customers as they implement this change?In this episode Tom Clarke (Director, Mtech Access) explored all this and more with Steve Reed (Head of Community Services, York Teaching Hospital NHS FT) and Dr Viren Mehta (V...
2022-08-091h 00
Pharma Market Access Insights - from Petauri EvidenceClinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS roleSend us a textWhat roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how can industry best support these new decision-makers?Tom Clarke (Director, Mtech Access) explores all this and more with Tom Kallis (Senior Clinical Pharmacist, East Cornwall PCN).They explore the origins of the Clinical Pharmacist role and how it has become a key part of the primary care landscape, to understand how the responsibilities of those in the role have been growing. They discuss examples of specific, surprising, ways...
2022-08-011h 00
Pharma Market Access Insights - from Petauri EvidenceTransforming systems and care pathways for an integrated NHSSend us a textAs the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, and what does this look like in reality for local systems and populations?Tom Clarke (Director, Mtech Access) explores all this and more with Debbie Morgan, (Director of Service Improvement and Transformation, Cambridge University Hospitals NHS Foundation Trust).Learn more about this webinar at https://mtechaccess.co.uk/transforming-systems-care-pathways-nhs/ and discover our NHS insight services at https://mtechaccess.co.uk/uk-nhs-insights/In this #WhispersWordsofWisdom webinar...
2022-06-211h 00
Pharma Market Access Insights - from Petauri EvidenceDigital value payer communication tools: How to meet the needs of your internal stakeholders and customersSend us a textOur experts in health economics, value communication, design and digital discuss how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams and KAMs, and healthcare customers. What does a best-in-class value communication tool look like in 2022? What are the key considerations when developing a new payer value toolkit? And what should Pharma and Medtech companies look for in a consultancy partner?For this webinar we brought together representatives from our health economics (Anthony Bentley), value communication (Lydia Crowe), design (Ryan...
2022-05-0439 min
Pharma Market Access Insights - from Petauri EvidencePopulation to Person: How will the NHS translate population health management into impactful, person-centred service change?Send us a textWhat does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health management into impactful service change and what will this look like for patients?Tom Clarke (Director, Mtech Access) explores all this and more with guest speaker Dr Steven Laitner (GP, Parkbury House Surgery). Steven and Tom explore how the NHS can translate the theory of population health management into practical service changes that improve care for patients. They consider the role data will play, the challenges of limited data and...
2022-03-1556 min
Pharma Market Access Insights - from Petauri EvidencePlanning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?Send us a textWhat does the ‘2022/23 priorities and operational planning guidance’ document mean for the NHS, for Integrated Care System (ICS) development and for an NHS workforce still battling COVID? How realistic and achievable are the priorities set out, and how can Pharma and Medtech best help NHS leaders to achieve these goals?Caroline Dawe (Deputy Director of Commissioning, Bristol, North Somerset and South Gloucestershire Clinical Commissioning Group [CCG]) joins Tom Clarke (Director, Mtech Access) to explore all this and more. The episode was first released live as a webinar on Friday 28th J...
2022-02-1159 min
Pharma Market Access Insights - from Petauri EvidenceThe evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel DiscussionSend us a textPharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how Pharma and Medtech can best support the NHS in 2022.We were joined by some of Mtech Access’s closest and most insightful friends:- David Thorne (Director, Mtech Access and Well Up North PCN) our Policy expert- Patrick McGinley (Head of Costing and Service Line Reporting, Maidstone and Tunbridge Wells NHS Trust) our Hospitals and Finance expert...
2022-01-171h 02
Pharma Market Access Insights - from Petauri EvidenceOptimising the NHS – How will medicines be valued in integrated systems?Send us a textHow will medicines be valued in the newly integrated world of the NHS? What are the risks and benefits of a single national formulary? What else is changing? And what does this mean for market access?Ellen Rule (Programme Director of the Gloucestershire Integrated Care System [ICS] and Director of Transformation and Service Redesign, Gloucestershire Clinical Commissioning Group [CCG]) joins Tom Clarke (Director, Mtech Access) to explore all this and more. Tom Clarke and Ellen Rule discuss the key points highlighted in her recent proposals
2021-12-2154 min
Pharma Market Access Insights - from Petauri EvidenceA new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales)Send us a textHow are healthcare systems looking differently at their population to deliver better care and what does this mean for future decision-making? How might the NHS re-imagine the hospital? What benefits can we expect from novel technologies, and can the NHS develop system resilience to improve healthcare outcomes?Dr Phil Webb (Chief Executive of Respiratory Innovation Wales) joined Tom Clarke (Director, Mtech Access) to explore all this and more. Re-imagining the hospital, investing in novel technologies, and developing system resilience to improve healthcare outcomes were all discussed. This e...
2021-10-0159 min
Pharma Market Access Insights - from Petauri EvidenceInnovations to address health inequalities in the NHS and how Pharma and Medtech can helpSend us a textHow can the NHS address health inequalities through innovation? How can new health technologies help improve population health? How can Pharma, Medtech and the wider life sciences industry support the NHS with these goals? And what does the NHS’ ambitions in this area mean for your market access strategy?Jon Siddall (Chief Executive of the South West Academic Health Science Network [AHSN]) joins Tom Clarke (Director, Mtech Access) to explore these questions and more.Before joining the South West AHSN as CEO in April 2020, Jon sp...
2021-09-1059 min
Pharma Market Access Insights - from Petauri EvidenceThe hidden heroes of the NHS - The role of ambulance Trusts in keeping patients and systems movingSend us a textWhat role do Ambulance Trusts play in the success of the wider NHS? How might urgent and community care evolve as we head to integration as part of a joined-up system? How will an integrated ambulance service support system redesign to keep people out of hospital, and provide more proactive care to those who need it most?Helen Ray (Chief Executive of North East Ambulance Service NHS Foundation Trust) joins Tom Clarke (Director, Mtech Access) to discuss the role Ambulance Trusts play in delivering care. This role f...
2021-07-0659 min
Pharma Market Access Insights - from Petauri EvidencePopulation to person - How will the voice of the individual drive health and care development?Send us a textPopulation health management is often talked about in top-down terms, but how seriously will the needs of individuals be taken as systems develop? How will personal needs inform care delivery? Why will the patient voice play a very different role in the NHS of the future?Steph Edusei (Chief Executive of St Oswald’s Hospice) joins Tom Clarke (Director, Mtech Access) to explore these questions and more. This episode was first released as a live webinar on Friday 21st May 2021.For more information visit: https://www.mtechaccess.co...
2021-06-021h 01
Pharma Market Access Insights - from Petauri EvidenceKnow your Place - where will power really sit in the new NHS - with Dr Steven Michael OBESend us a textWhat will a ‘Place’ look like? What will this new layer of the NHS mean in practice and what decision-making powers will Place leaders have?As the NHS starts its journey towards an integrated future, Dr Steven Michael OBE (Chair of East Cheshire Partnership) joins Tom Clarke (Director, Mtech Access) to talk ‘Place’, ‘Partnership’, ’Collaboratives’ and more.The UK Government’s Health and Care White Paper, along with other recent policy announcements, set out a major proposed reorganisation of the NHS in England. This includes the i...
2021-05-171h 01
Pharma Market Access Insights - from Petauri EvidenceHealth Economic Modelling for MedTech Innovation - What, Why and HowSend us a textAre you looking to launch a new medical technology, medical or diagnostic device in the UK, Europe or North America? Would you like to know how health economic modelling could support your market access journey?In this episode, converted from a recent live webinar, Calum Jones (Consultant Health Economist) and Nick Swart (Senior Health Economist) discuss what, why and how health economic models can support MedTech innovations to demonstrate value, achieve market access and reach more patients.Health economic modelling is becoming a...
2021-04-141h 00
Pharma Market Access Insights - from Petauri EvidencePharmacy, Medicines, and Specialised Commissioning in the new NHSSend us a textWhat changes can we expect to pharmacy, medicines management, and specialised commissioning in the new NHS? Professor Inderjit Singh (Chief Pharmacist at University Hospitals Birmingham) joins Tom Clarke (Director, Mtech Access) to explore all this and more. Professor Singh is one of the leading pharmacists in today’s NHS and is currently Chief Pharmacist at University Hospitals Birmingham NHS Foundation Trust. He has responsibility for the provision of the pharmacy service within the Trust and for ensuring appropriate governance of medicines. He provides strategic oversight into commercial pharmacy matters and strategic sup...
2021-04-1258 min
Pharma Market Access Insights - from Petauri EvidenceHeads at the heart of the NHS: How mental health is central to everything in the new NHS - with Brent Kilmurray (Chief Executive of Tees, Esk and Wear Valleys NHS Foundation Trust)Send us a textWith mental health services facing unique challenges, Brent Kilmurray (Chief Executive of Tees, Esk and Wear Valleys NHS Foundation Trust), joins Tom Clarke (Director, Mtech Access) to explore the challenges of leading mental health services in the NHS.As Chief Executive of the Tees, Esk and Wear Valleys NHS Foundation Trust, and with almost 20 years of experience in strategic and operational roles in the NHS, Brent is well placed to explore the challenges facing mental health services and what can be done to deliver change in this area.The...
2021-02-0545 min
Pharma Market Access Insights - from Petauri EvidenceIs prevention better than the cure? How can the NHS and public health work closer to improve population health?Send us a textDr Peter Brambleby (Independent Public Health Consultant) joins Tom Clarke (Director, Mtech Access) to discuss the role public health has played through the COVID pandemic and its importance to the population going forward.This webinar forms part of our monthly Whispers’ Words of Wisdom series, in which we have in‑depth, comprehensive conversations with senior colleagues from the NHS. We explore what their immediate priorities are, what they see as the greatest challenges faced by the NHS, and how the NHS might respond to these challenges.We were delighted to w...
2020-11-271h 00
Pharma Market Access Insights - from Petauri EvidenceUnderstanding the tipping point: When elective becomes selective in NHS surgerySend us a textSimon Parsons (Divisional Director of Surgery at Nottingham University Hospitals NHS Trust) joins Tom Clarke (Director, Mtech Access) to discuss how decisions, such as the postponement of non-urgent elective surgery, are made, the impact this has on patients and staff, and how the NHS might adapt to provide care for these patients.In addition to his role as Divisional Director of Surgery at Nottingham University Hospitals NHS Trust, Simon Parsons is a Consultant Oesophago Gastric Surgeon. He works as part of the team of gastro-oesophageal surgeons in Nottingham carrying out a...
2020-11-1638 min
Pharma Market Access Insights - from Petauri EvidenceLeading within an evolving, integrating system: insights from an NHS leaderSend us a textDiscover what it’s like to be a leader in today’s NHS and how industry can best support NHS leaders. Deborah Lee (Chief Executive of Gloucestershire Hospitals NHS Trust) speaks to David Thorne (Director, Mtech Access) about how she and her colleagues are responding to the challenges presented by the COVID-19 pandemic, the resultant backlog in care, and the latest policy changes. Deborah Lee has held the role of Chief Executive at Gloucestershire Hospitals NHS Trust since 2016. Prior to this she was Deputy Chief Executive and Chief Operating Officer at Unit...
2020-10-2158 min
Pharma Market Access Insights - from Petauri EvidenceIntegrated Care Systems: Separating fact from myth – insights from a system leaderSend us a textDr Claire Fuller (Senior Responsible Officer at Surrey Heartlands Health and Care Partnership) joins Tom Clarke(Director, Mtech Access) to discuss the evolving world of Integrated Care Systems (ICS). As Senior Responsible Officer for Surrey Heartlands Health and Care Partnership, Dr Fuller leads the delivery of plans to transform care for a population of over 850,000 people. Her role sees her collaborate with hospital, community, and primary care partners to introduce innovations that improve patient care.A practicing GP since 1995, Dr Fuller’s perspective on the NHS stretches from the fro...
2020-10-1558 min
Pharma Market Access Insights - from Petauri EvidenceThe Evolving NHS - Lessons for Pharma and Medtech - NHS insights webinar with David Thorne and Tom ClarkeSend us a textFrom capacity management to changing performance measures, discover what’s changing in the NHS, the impact on the NHS long-term plan and what all this means for the future of market access. Tom Clarke and David Thorne, from the Mtech Access NHS Insights & Interaction team, review some of the insights from our earlier series: ‘How is COVID-19 impacting the NHS?’, as well as exploring trends and challenges uncovered in conversation with our network of NHS Associates in our first 'Whispers Words of Wisdom' podcast.Tom and Da...
2020-10-091h 01
Pharma Market Access Insights - from Petauri EvidenceThe Role of the Independent Sector, Post-COVID with Jim Easton (CEO of Care UK)Send us a textWe are joined by Jim Easton (CEO of Care UK) to discuss the role of the independent sector in supporting the NHS and the wider care industry, both during the pandemic and in a post-COVID world. In this COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) is joined by NHS and other UK healthcare experts who offer real-world, first-hand insight into the challenges facing the NHS and explore the implications for market access, brand and HCP-facing teams, in pharmaceutical and medical device companies.In this episode, T...
2020-08-1136 min
Pharma Market Access Insights - from Petauri EvidenceThe Tech Perspective with Stephen Bourke (Co-Founder of Echo, The Online Pharmacy)Send us a textWe explore a different aspect of the COVID response, speaking with Stephen Bourke (Co-Founder of Echo), to learn how Echo and other tech companies have been supporting patients with new ways of accessing healthcare, throughout lockdown.In this COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) is joined by NHS and other UK healthcare experts who offer real-world, first-hand insight into the challenges facing the NHS and explore the implications for market access, brand and HCP-facing teams, in pharmaceutical and medical device companies. In this episode, T...
2020-08-0532 min
Pharma Market Access Insights - from Petauri EvidenceQuestions Time Special - Views from across the NHS; from costings to strategy to clinical careSend us a textIn this 'Questions Time' special we welcome a broad panel of practitioners from across the NHS to explore the themes of care delivery, collaboration, innovation and governance. Our panellists are:Cameron Ward (Interim Director of Strategy and Outcomes, Sefton CCG)Hilary Snowdon (Management Lead, West Northumberland PCN)Patrick McGinley (Head of Costing & SLR, Maidstone & Tunbridge Wells NHS Trust)Dr Su McCole (GP & Area Clinical Director)This episode is part of our COVID-19 series, where Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) asks experts holding operational, strategic and clinical roles a...
2020-07-301h 02